Gravitas

Family Business Expert Chrissy Myers: Five Tips For Making A Successful Family Business Transition

Retrieved on: 
Tuesday, January 30, 2024
Family, Outline of counseling, Gravitas, Sleep, AUI, Life, Affordable Care Act, Friends, Emotional intelligence, Care Act 2014, ACA, COVID-19, HR, Exercise

AKRON, Ohio, Jan. 30, 2024 /PRNewswire/ -- When it comes to a business transition, most family business owners "fly by the seat of their pants."

Key Points: 
  • AKRON, Ohio, Jan. 30, 2024 /PRNewswire/ -- When it comes to a business transition, most family business owners "fly by the seat of their pants."
  • That's the view of family business expert Chrissy Myers, author of the book Reluctantly Resilient: One CEO's Journey to Thriving in Leadership and Life (2023, Gravitas Press ).
  • Myers candidly shares her struggles as a business leader in a market upheaval, the challenges common in a family business and the stress she experienced as a widow and mom dating and building a healthy family.
  • Family business transition is difficult and requires skills of emotional intelligence.

Gravitas Medical Inc. Announces SECOND FDA Breakthrough Device Designation for its Entarik System; Pediatric Patients to Benefit from Enteral Nutrition Innovation!

Retrieved on: 
Wednesday, December 13, 2023
Adolescence, Infant, SAN, Food, Stomach, Incidence, Patient, Medicine, FDA, Breakthrough, Child, Diagnosis, Gastrointestinal tract, Gravitas, Pharmaceutical industry, Nursing

SAN FRANCISCO, Dec. 13, 2023 /PRNewswire-PRWeb/ -- Gravitas Medical Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted a second Breakthrough Device Designation to Entarik, the innovative Enteral Feeding System. This award allows Gravitas Medical to accelerate development and approval processes to expedite pediatric patient access to Entarik's revolutionary technology.

Key Points: 
  • SAN FRANCISCO, Dec. 13, 2023 /PRNewswire-PRWeb/ -- Gravitas Medical Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted a second Breakthrough Device Designation to Entarik, the innovative Enteral Feeding System.
  • This award allows Gravitas Medical to accelerate development and approval processes to expedite pediatric patient access to Entarik's revolutionary technology.
  • "This second designation recognizes the lifesaving potential of Entarik for pediatric and adolescent patients in addition to neonates."
  • "This second Breakthrough Designation recognizes the importance of the Gravitas Medical team's work and Entarik's potential to save lives of pediatric patients," concluded Hansen.

Basilea announces acquisition of novel clinical-stage antifungal for treatment of Aspergillus mold infections

Retrieved on: 
Thursday, October 19, 2023
FDA, Isavuconazonium, Gravitas, US Foods, Safety, I.V. (song), QIDP, LR, USD, Therapy, Patient, Infection, Pharmaceutical industry, Aspergillus, Allschwil

David Veitch, Chief Executive Officer of Basilea, stated: “This is the first transaction in the implementation of our strategy to expand our clinical-stage anti-infectives pipeline and to complement our portfolio of marketed products, Cresemba and Zevtera.

Key Points: 
  • David Veitch, Chief Executive Officer of Basilea, stated: “This is the first transaction in the implementation of our strategy to expand our clinical-stage anti-infectives pipeline and to complement our portfolio of marketed products, Cresemba and Zevtera.
  • Based on its novel mechanism of action which results in rapid fungicidal activity in vitro, BAL2062 could become a valuable treatment option against difficult-to-treat invasive mold infections.
  • To define the optimal positioning and the most efficient clinical development path, we will initiate a focused preclinical profiling program.
  • In addition, Basilea will pay tiered royalties on sales starting in the low single-digit percentage range, going to the mid-single-digit percentage range.

FDA Grants Breakthrough Device Designation to Gravitas Medical for Neonatal Patients Requiring Enteral Feeding

Retrieved on: 
Wednesday, September 27, 2023
Medicine, Gastrointestinal tract, Food and Drug Administration, Stomach, Incidence, Patient, SAN, Gravitas, Diagnosis, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Breakthrough, Food, Pharmaceutical industry, Medical device

SAN FRANCISCO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- Gravitas Medical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Entarik, the innovative Gravitas Feeding Tube System. This milestone signifies a major step forward in advancing neonatal healthcare by providing expedited access to this revolutionary technology for patients in need.

Key Points: 
  • Gravitas Medical announces U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Entarik, the innovative Gravitas Feeding Tube System.
  • SAN FRANCISCO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- Gravitas Medical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Entarik, the innovative Gravitas Feeding Tube System.
  • Entarik is designed to aid, in conjunction with institutional protocols, qualified operators (medical professionals) in the placement of the Gravitas Enteral Feeding Tube into the stomach of neonatal patients requiring enteral feeding.
  • Jorgen Hansen, CEO of Gravitas Medical, expressed enthusiasm about the Breakthrough Device designation, stating, "The Breakthrough Device designation promises to accelerate the introduction of Entarik for neonatal patients."

Global Loyalty Programs Market 2023: Restaurant Brands are Turning to Subscription Models in the Next Big Loyalty Trend

Retrieved on: 
Wednesday, July 26, 2023
Spend, Partnership, NFT, Polygon, Starbucks, Amazon, US, Non-fungible token, Polygon (blockchain), Barnes & Noble, Lotte Corporation, Growth, Salesforce, Panera Bread, Semiconductor, Marketing, Cryptocurrency, Online shopping, Gravitas

The global loyalty market is expected to grow by 12.7% on annual basis to reach US$135.9 billion in 2023.

Key Points: 
  • The global loyalty market is expected to grow by 12.7% on annual basis to reach US$135.9 billion in 2023.
  • In value terms, the global loyalty market has recorded a CAGR of 13.1% during 2018-2022.The global loyalty market will continue to grow over the forecast period and is expected to record a CAGR of 12.2% during 2023-2027.
  • Furthermore, the market growth will also be driven by the adoption of loyalty programs across different industries.
  • Restaurant brands are turning to subscription models in the next big loyalty trend.

Enforcement Notice - Hearing - CIRO to Hold Protective Order Hearing in the Matter of Gravitas Securities Inc.

Retrieved on: 
Thursday, June 1, 2023
The central science, IIROC, Investment Industry Regulatory Organization of Canada, Mutual Fund Dealers Association, Wind, Investment, Hearing, Gravitas, Enforcement, CIRO, Financial adviser, Property management

TORONTO, June 1, 2023 /CNW/ - A protective order hearing has been scheduled before a hearing panel of the Investment Dealer Division of the Canadian Investment Regulatory Organization (CIRO) in the matter of Gravitas Securities Inc. (Gravitas).

Key Points: 
  • TORONTO, June 1, 2023 /CNW/ - A protective order hearing has been scheduled before a hearing panel of the Investment Dealer Division of the Canadian Investment Regulatory Organization (CIRO) in the matter of Gravitas Securities Inc. (Gravitas).
  • CIRO Staff will seek an order pursuant to sections 8212 and 8426 of the Investment Dealer and Partially Consolidated Rules.
  • In particular, CIRO Staff will seek an order for the suspension of Gravitas' membership as a result of: (1) Gravitas becoming capital deficient; and (2) Gravitas advising of its intention to wind up its business as an investment dealer.
  • Members of the public who would like to attend the hearing should contact CIRO's National Hearing Officer at [email protected] to obtain the details.

Ohmyhome to Present at the LD Micro Invitational XIII Conference in Los Angeles on June 6-8, 2023

Retrieved on: 
Tuesday, May 30, 2023
Interest, Growth, The Beverly Hills Hotel, Environment, Nature, Gravitas

Interested parties may request a one-on-one meeting by contacting their LD Micro conference representative or emailing [email protected] .

Key Points: 
  • Interested parties may request a one-on-one meeting by contacting their LD Micro conference representative or emailing [email protected] .
  • Ohmyhome management will also be in attendance as a guest at the Gravitas Securities 4th Annual LA Summit being held June 4-6, 2023 at the Beverly Hills Hotel in Los Angeles, CA.
  • Should interested parties want to meet with the Company, please contact your Gravitas representative or email [email protected] .
  • In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing.

BMG MUSIC ISSUES 2 LP VINYL RE-RELEASE EDITION OF ASIA'S 2008 PHOENIX REUNION ALBUM

Retrieved on: 
Friday, May 26, 2023
Heat of the Moment, Emerson, Lake & Palmer, MTV, Alpha, Cancer, Omega, The Buggles, XXX, Bertelsmann Music Group, Collection, Moment, Gravitas, News, Music, YES, Billboard, PHOENIX

NEW YORK, May 26, 2023 /PRNewswire/ -- BMG Music has released the legendary ASIA studio album Phoenix with a highly collectible double vinyl edition, available today, May 26th. Asia are the multi-platinum selling English rock band who formed in 1981 and celebrated its 40th anniversary in 2021. Their 1982 self-titled debut album reached number one in several countries, including nine weeks topping the US charts, with lead single 'Heat Of The Moment' making the top 40 in over a dozen, including US #4. 

Key Points: 
  • NEW YORK, May 26, 2023 /PRNewswire/ -- BMG Music has released the legendary ASIA studio album Phoenix with a highly collectible double vinyl edition, available today, May 26th.
  • Asia are the multi-platinum selling English rock band who formed in 1981 and celebrated its 40th anniversary in 2021.
  • In 2008, the album Phoenix followed to critical acclaim and the delight of its still very loyal fan base.
  • Phoenix album (previously unreleased on LP) was the band's first studio album with its original line-up.

Assure Holdings to Present at the Gravitas 6th Annual Growth Conference

Retrieved on: 
Tuesday, February 28, 2023
Gravitas, PST, Conference, Cryptocurrency

DENVER, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, is pleased to announce it will be presenting at the Gravitas 6th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel on Thursday, March 2nd, 2023, in Vancouver, British Columbia.

Key Points: 
  • DENVER, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, is pleased to announce it will be presenting at the Gravitas 6th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel on Thursday, March 2nd, 2023, in Vancouver, British Columbia.
  • John A. Farlinger, Assure’s executive chairman and CEO, is scheduled to present on Thursday, March 2nd, 2023, at 1:20 p.m. PST.
  • Mr. Farlinger will also be fielding investor questions, hosting individual investor meetings, and participating on a panel discussion during the one-day in-person conference.
  • John A. Farlinger, Assure’s executive chairman and CEO, commented, “The Gravitas Growth Conference is an excellent venue for us to discuss the progress we are making towards reducing our cost structure and accelerating our path to profitability.

Permex Petroleum to Present at the Gravitas 6th Annual Growth Conference

Retrieved on: 
Monday, February 27, 2023
CSE, NOT, FOR, Gravitas, FSE, Conference

VANCOUVER, British Columbia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Permex Petroleum Corporation (CSE: OIL) (OTCQB: OILCF) (FSE: 75P) ("Permex" or the "Company"), is pleased to announce it will be presenting at the Gravitas 6th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel on Thursday, March 2nd, 2023, in Vancouver, British Columbia.

Key Points: 
  • NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
    VANCOUVER, British Columbia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Permex Petroleum Corporation (CSE: OIL) (OTCQB: OILCF) (FSE: 75P) ("Permex" or the "Company"), is pleased to announce it will be presenting at the Gravitas 6th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel on Thursday, March 2nd, 2023, in Vancouver, British Columbia.
  • Mehran Ehsan, President, Chief Executive Officer & Director, is scheduled to present on Thursday, March 2nd, 2023, at 11:30 AM PST.
  • Mr. Ehsan will also be fielding investor questions, hosting individual investor meetings, and participating on a panel discussion during the one-day in-person conference.
  • Gravitas’ 6th Annual Growth Conference will feature leaders at the forefront of their industries as well as investors from Canada, the United States, and abroad.